Introduction
The immune system specifically recognises and eliminates foreign agents thereby protecting the host against infection. During maturation of the immune system, immune cells that react against self-tissues are eliminated providing an immune system that is "tolerant" to self. More recently, researchers have realised that autoimmunity is a natural phenomenon, with self-reactive antibodies and autoimmune cells present in all individuals. A combination of genetic predisposition and environmental factors contribute to the development of autoimmune disease. Because many autoimmune diseases start at a relatively young age and continue throughout life, they have a disproportionate effect on public health; furthermore, most autoimmune diseases are chronic in nature requiring a lifetime of care. Understanding the mechanisms that lead to dysregulation of the immune response resulting in autoimmune disease is necessary to develop better therapies to treat and possibly even prevent these diseases.
II. A Brief Over-View Of Immune System
One definition of the immune system is that it is an intricate set of cellular, chemical and soluble protein mechanisms, intended to shield the body against alien substances such as infections and tumor cells, without attacking self-molecules. The distinction between self-molecules and alien substances occurs through intricate mechanisms that are dependent on certain recognition molecules present on the surface of immune competent cells, specifically, T and B lymphocytes. A small percentage of T and B lymphocytes form a normal part of the immune cell pool. Tolerance is preserved by the controlled interactions of various cell types and soluble mediators; however, in certain environments, tolerance can be broken resulting in an autoimmune pathogen.  Autoimmunity is defined as the development of immune system reactivity in the form of auto-antibodies and T-cell responses to self-structures. There are many known autoimmune diseases ranging from tissue specific disorders to systemic disorders.  The definition of autoimmune disease: This definition includes a variety of diseases which can be described by the irregular functioning of the immune system that causes an individual"s immune system to generate antibodies which attack their own body tissues.  Immune tolerance is defined as specific non-reactivity of the immune system to a particular antigen, which is capable under other circumstances of inducing an immune response. Most immune system cells are white blood cells; lymphocytes are of one type. There are several types of lymphocytes in the adaptive immune system; each has a specific job to perform. T-cells help identify and eliminate antigens, and B-cells produce antibodies that each attach to one special antigen and mark it for destruction by other immune system cells. T-cells are critical immune system cells that help to destroy infected cells and coordinate overall immune response. There are three types of T-cells:  Helper T-cells, which signal B-cells to produce stronger antibodies  Cell-killing (cytotoxic) T-cells which produce molecules that destroy cells carrying antigens  Suppressor T-cells which dampen other immune responses. 1 Other key players in autoimmune disease are messenger molecules called cytokines and chemokines. Cytokines are proteins that can activate immune cells and affect nonimmune processes and thereby cause inflammation and damage. Chemokines are small molecules that attract other immune cells and can contribute to the invasion and inflammation of the target organ. For example, overproduction of chemokines in the joints of people with rheumatoid arthritis may result in invasion of the joint space by destructive immune system cells such as macrophages, neutrophils and T-cells.
III. Classification of Autoimmune Diseases
For clinicians, autoimmune diseases appear to be either systemic (e.g. systemic lupus erythematosus) or organ-specific (e.g. Type 1 diabetes mellitus). This classification, although clinically useful, does not necessarily correspond to a difference in causation. A more useful division distinguishes between diseases in which there is a general alteration in the selection, regulation or death of T cells or B cells and those in which an aberrant response to a particular antigen, self or foreign, causes autoimmunity. An example of a general defect is the absence of the Fas protein or its receptor-proteins involved in cell death-and a representative antigen specific disorder is the demyelination syndrome that follows enteric infection Campylobacterjejuni. This classification is useful in deciding on therapy, which may differ according to the pathogenic mechanism. Alterations that lower the threshold for the survival and activation of autoreactive B cells often cause the production of multiple autoantibodies, as in the case of the antinuclear and anti-DNA antibodies in systemic lupus erythematosus. [2] [3] [4] [5] [6] Low levels of these autoantibodies are the rule in all people. Genetic alterations with global effects on the function of regulatory T cells or cytokine production often leads to inflammatory bowel disease. 7, 8 This process may reflect enhanced activation of T cells with an exuberant response to gut flora.
IV. Genetic Risk Factors
The development of autoimmune diseases depends on a combination of genetic and environmental factors. Most autoimmune diseases are thought to be polygenic, involving more than one gene. There is familial clustering, and the rate of concordance for autoimmune disease is higher in monozygotic twins than in dizygotic twins.
9-11 A few autoimmune diseases, such as autoimmune lymphoproliferative syndrome and the syndrome of autoimmune polyglandular endocrinopathy with candidiasis and ectodermal dysplasia (APECED), are due to mutations in single gene. Even in these conditions, other genes modify the severity of disease and not all who possess the mutant gene manifest the disease.
Most autoimmune diseases are multigenic, with multiple susceptibility genes working in concert to produce the abnormal phenotype. In general, the polymorphisms also occur in normal people and are compatible with normal immune function. Only when present with other susceptibility genes do they contribute to autoimmunity.
12, 13 Some of these genes confer a much higher level of risk than others; for e.g. the major histocompatibility complex makes an important contribution to disease susceptibility. Most autoimmune diseases are linked to a particular class I or II HLA molecule, 14 but this association may require linkage with another gene such as that encoding tumor necrosis factor α (TNF-α) or complement. Human lymphocyte antigen or HLA haplotype, is the best available predictor of developing an autoimmune disease. The likelihood of developing similar autoantibodies relates directly to sharing HLA haplotypes with family members and the probability is even greater if two haplotypes rather than one are shared. Thus, heredity accounts for about one-third of the risk of developing an autoimmune disease, while noninherited, environmental factors account for the remaining 70% risk.
V. Environmental Factors
Environmental factors may have various roles in promoting, causing or modifying autoimmune diseases. If, and when specific environmental factors contribute to autoimmune diseases, they may well determine the onset of illness, the nature of initial manifestations, or be a determining factor on whether an autoimmune disease contained within an individual might occur at all. 15 Environmental factors are one of the most important initiators determining the time and type of autoimmune disease when one is manifested. The type of disease in an individual, in an autoimmune prone family, can be determined by a specific combination of various infectious agents, chemicals, drugs and vaccines. including direct viral damage, release of cryptic self-peptides, antigenic spread, molecular mimicry, bystander activation and the adjuvant effect. Molecular mimicry is the concept that antigens of the microorganism closely resembles self-antigens and when an infection occurs, autoimmunity is induced.
Bystander activation may occur when the immune response is non-specifically stimulated by the infection resulting in activation of autoimmunity in genetically susceptible individuals. The adjuvant effectdescribes the specific activation of the innate immune response by microbial antigens as occurs, for e.g., during administration of adjuvants in vaccines. A number of autoimmune diseases can be induced experimentally by administering self-antigen with adjuvant, such as rheumatoid arthritis with collagen and myocarditis with cardiac myosin.
Smoking and autoimmune diseases-
Tobacco smoking is one of the most powerful factors that could prompt autoimmune diseases. Smoking has been associated with systemic lupus erythematosus (SLE); the prevalence rate, ratios for current and past smoking for the development of the disease has been found to be 1.6. The prevalence of smoking with rheumatoid arthritis is even more established. Smoking interacts genetic risk factors such as HLA-DR alleles, making up to an estimated 21-fold risk of disease. Smoking can contribute to autoimmunity by various mechanisms; it causes tissue damage and increases apoptosis through production of free radicals, release of metalloproteinase, and the induction of Fas expression on lymphocytes. Smoking also provokes inflammation as it causes an increase in fibrinogen levels, induces leucocytosis, and elevated C-reactive protein, intercellular adhesion molecule-I and E-selectin.
VI. Antibody-Mediated Damage
Antibodies or immunoglobulins are a family of glycoproteins present in the serum and tissue fluids of all mammals. Antibodies can be carried on the surface of B-cells, acting as receptors, or free in the blood and lymph. Specific binding of antigens causes B-cells to produce large amounts of antigen-specific antibody. These antibodies provide critical protection against infectious microorganisms immediately following infection and are the key protective immune response induced by vaccination. Similarly, self-reactive or autoantibodies are important in clearing cellular debris induced by inflammation or physical damage to the body.
A common feature of all autoimmune diseases is the presence of autoantibodies, which are an important factor in the diagnosis or classification of autoimmune diseases. Due to the chronic nature of most autoimmune diseases, autoantibodies appear long before clinical symptoms; in fact, the risk of developing an autoimmune disease rises from about 10% if one autoantibody is present to around 60-80% if three autoantibodies are present for a particular autoimmune disease. Autoantibodies can induce damage to the body by binding to self-tissues, activating the complement cascade and inducing lysis. This occurs in certain forms of haemolytic anemia when autoantibodies bind to red blood cell surface antigens inducing lysis of red blood cells.
VII.
Cell 
VIII.
Tolerance Mechanisms of self-tolerance, defined as a state of nonresponsiveness to self, can be divided into central and peripheral tolerance. In central tolerance, immature lymphocytes in the bone marrow (B-cells) and thymus (Tcells) that recognise self-antigens with high affinity die by apoptosis or programmed cell-death. In peripheral tolerance, mature self-reactive lymphocytes are inactivated, killed or turned off by regulatory mechanisms including functional anergy, ignorance and suppression by regulatory T-cells. Defects in tolerance leading to autoimmune disease may occur in one or multiple tolerance mechanisms. For e.g. changes in the apoptotic cell death or survival or disturbances in clearing apoptotic cells, are thought to be involved in the pathogenesis of a number of autoimmune diseases such as rheumatoid arthritis, lupus and Hashimoto"s thyroiditis.
IX.
Risks For Developing Autoimmune Diseases Table 1 gives examples of autoimmune disorders and risks for developing these disorders depending on the family history Table 2 gives various types of autoimmune diseases and their symptoms
X. Profiles Of Autoimmune Diseases

XI. Future therapeutic approaches for treating autoimmune diseases
Four general approaches to therapy are being explored ( Table 3) : altering thresholds of immune activation, modulating antigen-specific responses, reconstituting the immune system with autologous or allogenic stem cells, and sparing of target organs.
Interference with costimulation, signalling, chemokines and other molecules critical to immune activation is designed to restore homeostasis in the immune system and dampen the autoimmune response. It is based on the concept that small changes in the availability of proteins that control interactions between cells or participate in intracellular signalling can divert the immune system away from autoreactivity. Antigen-specific therapies aim to induce tolerance to a particular antigen. Exposure of the immune system to autoantigens or appropriate peptides delivered either by ingestion to induce oral tolerance 20 or by ingestion 31 has worked well in animals but not in humans. 32 Perhaps, this approach can only work during the initial activation of autoreactive cells, because once disease is clinically apparent, the immunologic milieu may be inflammatory and epitope spreading may have occurred. An approach involving stem-cell transplantation has engendered much excitement recently and pilot studies of reconstitution with autologous and allogenic stem cells are proceeding in patients with systemic lupus erythematosus, rheumatoid arthritis, scleroderma and multiple sclerosis 26, [33] [34] [35] with a hope to restore homeostasis with regulatory cells.
XII. Conclusion
The complex causes of autoimmune diseases not only present a challenge to the development and testing of new therapies but also offer a framework that allows the identification of subgroups of patients who might benefit from particular approaches. Although we will encounter both successes and setbacks, continued studies of autoimmune diseases in humans and animals are necessary to help identify the most appropriate strategies for each disease. Females are 2-3 times more likely to be affected than males; risk for parents and siblings of an affected individual is about 2-4.5% Scleroderma 1% recurrence risk for first degree relatives Sjogren"s syndrome 9/10 patients are females; 50% of cases occur alone while 50% of cases occur in the presence of another autoimmune disease Systemic lupus erythematosus 9/10 patients are females; first degree relatives have a 8-9 fold increased risk over the general population Type I or immune mediated diabetes mellitus Recurrence risk is 4%; up to 50% if multiple affected relatives 
